When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?-a critical review of LITESPARK-004 results.

ABSTRACT:

SUBMITTER: Sener U 

PROVIDER: S-EPMC12170006 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature